Manage Your Liver
Q:

What is NAFLD & NASH?

A:

Nonalcoholic fatty liver disease (NAFLD) is the buildup of extra fat in liver cells that is not caused by alcohol. In most people, early forms of NAFLD are unlikely to cause harm. However, if the fat continues to build up, it can eventually lead to inflammation or fibrosis of the liver.

 

Nonalcoholic steatohepatitis (NASH) is the more severe form of NAFLD. NASH causes liver inflammation and damage by an accumulation of fat in the liver which is not related to alcohol. NAFLD & NASH tends to develop in people who are overweight or obese, or have diabetes, high cholesterol or high triglycerides.

 

Up to 25% of adults with NASH may have cirrhosis.

 

Most people with NASH are between 40 and 60 years old. It is more common in women than in men. NASH is one of the leading causes of cirrhosis in adults in the US.

 

Causes

Things that put people at risk for NAFLD and NASH:

  • Obesity
  • Diabetes
  • High cholesterol and triglycerides
  • Metabolic syndrom

 

Signs and Symptoms

  • Loss of appetite
  • Fatigue
  • Nausea and vomiting
  • Abdominal pain

 

Diagnosis

An ultrasound of the liver can suggest the presence of a fatty liver. Other imaging studies may be used as well such as a computed tomography (CT) scan, or magnetic resonance imaging (MRI). In some cases, your doctor may advise a liver biopsy, it will help determine the exact cause.

 

Treatment

Currently, there is no medication proven to effectively treat fatty liver disease, if the main causes are related to obesity, diabetes and dyslipidemia. The standard recommendations to fatty liver disease patients are to reach a healthy weight, avoid alcohol, follow a healthy diet and exercise regularly.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
NAFLDNASHFatty LiverNonalcoholic fatty liver diseaseNonalcoholic steatohepatitis
Related Questions
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us